MSD Animal Health's equine division has launched a new series of materials to support its Keeping Britain's Horses Healthy Campaign.
For veterinary practices, there's a Vet Reception Pack designed to help receptionists educate owners why they should vaccinate and the benefits of preventive healthcare.
For yards, there are posters giving guidance and advice on prevention of Infectious Respiratory Disease and the steps which should be taken to control a potential outbreak. They can be tailor made for an individual yard.
Peter Young, MSD Animal Health Equine Business Manager said: "Our first wave of support materials focused very much on equine vets and owners - helping raise awareness of the importance of preventive healthcare and driving owners towards vets for advice. This phase of materials helps support yard owners and receptionists, aiming to fill some of those communications gaps where advice and guidelines on individual horse's vaccination requirements and yard protocols can play a vital role in preventing the spread of disease and controlling outbreaks."
Keeping Britain's Horses Healthy is a national campaign to educate horse owners on endemic infectious disease, vaccination, herd immunity and the importance of preventative healthcare. It includes a range of educational materials for veterinary surgeries and direct to owners. The campaign is supported by a national PR, advertising and social media programme, together with a dedicated website www.healthyhorses.co.uk. The website, aimed at driving owners back to their veterinary practices, includes a vet finder, exclusively for equine practices, and healthcare information.
For full details of the launch programme, talk to your account manager, call 01908 685685 or visit www.healthyhorses.co.uk.
The Animal Health Trust is appealing to veterinary surgeons and nurses to encourage clients who keep their horses on premises that have been affected by Equine Grass Sickness to sign up to the second year of its nationwide EGS vaccine trial.
Equine Grass Sickness (EGS) occurs predominantly in Europe, with Britain experiencing the highest incidence worldwide. In 2014, 59 cases of EGS were reported through the EGS Surveillance Scheme, but it is likely that this represents only a fraction of cases occurring annually throughout Britain.
Almost all cases of EGS occur in horses with access to grazing. The AHT says there is growing scientific evidence to suggest that the disease may be caused by the bacterium Clostridium botulinum type C, commonly found within soil and capable of producing neurotoxins to which horses are particularly sensitive. EGS occurs when a combination of risk factors trigger the production of these toxins within the horse's intestinal tract, causing damage to the nervous system and paralysis of the gut.
As similar equine diseases such as tetanus and botulism can be prevented by vaccination, it is theoretically possible that a vaccine could prevent EGS. To this end the AHT, in collaboration with the Universities of Edinburgh, Liverpool and Surrey launched the EGS field vaccine trial in 2014 in order to establish whether a vaccine could indeed be effective in reducing the risk of the disease. The trial is funded by a number of sources including Neogen Corporation; Animal Welfare Foundation; Horserace Betting Levy Board; Racing Foundation; Moredun Foundation Equine Grass Sickness Fund; Hong Kong Jockey Club; The British Horse Society and the EB Moller Charitable Trust.
Now entering its second year, the EGS vaccine trial involves enrolled horses and ponies receiving either a course of the C. botulinum type C toxoid vaccine or an inactive placebo, as well as an annual booster. The incidence of EGS is monitored throughout the trial to determine the efficacy of the vaccine, and enrolled horses and ponies are closely monitored through regular follow-ups for the duration of the trial.
With 60% of EGS cases occurring during April - June, the highest risk season for EGS is fast approaching. The AHT is appealing to owners who keep their horses on premises that have had at least one case of EGS in the past three years to enrol their horse in the vaccine trial and provide an invaluable contribution to this pioneering research prior to these high risk months. Veterinary practices with clients who fit this description are asked to help the recruitment process by encouraging suitable cases to sign up to the trial.
Dr Jo Ireland, the AHT's Equine Grass Sickness Research Co-ordinator, said: "We have been delighted with the overwhelmingly positive response to the EGS vaccine trial and many owners have welcomed the chance to be a part of such important research. We don't want any eligible horse owners to miss out on the opportunity to contribute towards a potential breakthrough in the prevention of EGS, so we are encouraging more owners to enrol their horses on the trial this year."
To find out more about the vaccine trial or how clients can enrol horses and ponies, visit the AHT's dedicated EGS website www.equinegrasssickness.co.uk or email equinegrasssickness@aht.org.uk.
The RCVS has announced the launch of its final consultation in the latest review of the Practice Standards Scheme (PSS), and is seeking feedback on the proposed detail of the revised Scheme.
The College says that in particular, it needs feedback about the new system of Awards for RCVS-accredited practices.
Following the College's commitment to review the PSS every five years, this is the second such review since the voluntary practice accreditation system was launched in 2005. After gaining extensive feedback from PSS members and the wider profession through previous consultations and focus groups, and the collaborative approach taken by members of the Practice Standards Group, there have been a number of significant redevelopments to the Scheme, which are due to be rolled out later this year.
The revised Scheme will no longer just consider facilities and equipment at a particular site, but will focus on all areas of the practice, emphasising the outcomes and behaviours that impact on the veterinary care of animals. Whilst the existing accreditation categories of Core Standards, General Practice and Veterinary Hospital will remain, the revised Scheme will provide a pathway for practices to improve and more easily demonstrate where they excel.
Jacqui Molyneux, Chairman of the Practice Standards Group said: "One of the most significant additions to the Scheme is that practices will be able to apply to be inspected for additional Awards in specific areas. If successful, they would then be able to promote themselves as 'Good' or 'Outstanding' in these areas to their clients.
"The main aim of this consultation is to seek feedback on the Awards, and to check we have set the Awards criteria appropriately, so I would urge the profession to have a look at the proposed framework, and to send us their views."
The consultation, which is available to complete via the RCVS website, also seeks feedback on the guidance that's provided to help practices meet the Scheme requirements, along with a small number of questions about specific areas. The requirements themselves remain largely unchanged, so are not subject to review.
The modules, requirements, guidance and Awards framework for small animal, equine and farm animal practices are detailed in three separate documents that are available to download from www.rcvs.org.uk/pssconsult2015. This page also contains further details about the consultation and instructions on how to submit feedback.
The consultation is open until 5pm on Monday, 23 March 2015.
The RCVS is encouraging vets to nominate members of their nursing team for this year's VN Golden Jubilee Award, which recognises exceptional contribution to veterinary nursing.
The award was launched in 2011 to celebrate the 50th anniversary of the first RCVS veterinary nursing training course and recognises those who have made an outstanding contribution to the profession, animal welfare and/or patient care. Nominees can be registered veterinary nurses, veterinary surgeons or lay people.
Nomination forms need to be submitted by 5pm on Friday 24 April. The principal nominator must be a registered veterinary nurse or veterinary surgeon, although the two supporting proposers can be lay people.
Kathy Kissick, Chair of VN Council, said: "One of the main priorities of VN Council in the coming years is to raise levels of awareness of registered veterinary nurses, and awards which recognise the importance of VNs in the context of the veterinary team and animal welfare are crucial to enhancing the profession's profile.
"Therefore I would encourage veterinary nurses and veterinary surgeons to think about those VNs who go above and beyond the call of duty for their cause and who would be excellent ambassadors for the profession and nominate them for the Golden Jubilee Award."
Last year's winner was Hayley Walters who was recognised for her contribution to animal welfare through her teaching, clinical and international outreach work. Previous recipients were Jean Turner in 2011 and Sue Badger in 2012. No award was made in 2013.
The nomination form for the VN Golden Jubilee Award can be downloaded from www.rcvs.org.uk/goldenjubilee
The winner will be chosen by a panel of VN Council members and will receive the Award at RCVS Day - the College's Annual General Meeting and Awards Day - on Friday 10 July 2015.
For further information about making a nomination for the award contact Annette Amato, Deputy Head of Veterinary Nursing, on a.amato@rcvs.org.uk or 020 7202 0713.
International Cat Care has launched a competition in which veterinary practice staff are invited to take a 'selfie' of themselves with their favourite cat and upload it to the International Society of Feline Medicine (ISFM) Facebook page (www.facebook.com/ISFMcats), where cat lovers from around the world can vote for their favourite.
The Cattitude competition is designed to raising awareness of the charity's global Cat Friendly Clinic initiative.
The photograph that gets the most Facebook 'likes' will be used by the charity to help raise awareness of the Cat Friendly Clinic programme, which aims to promote the wellbeing of cats visiting or being hospitalised in a veterinary practice. Accredited Cat Friendly Clinics fulfil a set of broad criteria that show they recognise the specific needs of cats and their owners, and place cat welfare high in their practice priorities. Cat owners in turn are able to seek out clinics that have taken steps to help them overcome common barriers to clinic visits and reduce the stress of their pet.
The Cattitude competition runs from now until the 24th April. The winning staff member will receive £200 worth of John Lewis vouchers and the practice £400 worth of Thames Medical vouchers to be spent on feline-friendly equipment.
Practices may upload as many photos as they like to the Facebook page, and will be able to encourage clients to 'Like' their photos with campaign support materials which include downloadable in-clinic display posters, a series of supplied posts for their own Facebook page, written copy for their own clinic newsletter or email along with a proforma press release they can send to their local newspapers and publications.
Clinics can find more information on taking part in the Cattitude competition at www.facebook.com/ISFMcats orwww.icatcare.org/cattitude. Details of the ICC Cat Friendly Clinic initiative and accreditation can be found atwww.catfriendlyclinic.org along with a list of already-accredited vet clinics.
Warwick Seymour-Hamilton, a former veterinary surgeon who practised in Kent, has had his third application for restoration to the Register refused by the RCVS Disciplinary Committee this week.
Mr Seymour-Hamilton was struck off in 1994 following an inspection of his premises, equipment and facilities in Orpington, which were found to be in such poor condition that it constituted a risk to the health and welfare of animals brought to the practice and brought the profession into disrepute.
Mr Seymour-Hamilton had made two previous restoration applications in July 1995 and June 2010. Both of these were refused on the grounds of poor preparation for re-entering practice life as, in both cases, he had made no attempt to engage in continuing professional development or visit and observe other veterinary practices.
Representing himself at this week's hearing, Mr Seymour-Hamilton said that, since the 2010 hearing, he had further developed an interest in herbal medicine and, after visiting a number of veterinary practices in continental Europe, had attended the College of Naturopathic Medicine in Dublin, gaining a qualification in herbal and naturopathic medicine. He told the Committee that he currently worked as a herbalist and naturopath with human patients but wanted to widen his work and research to include animal patients.
The Committee was concerned by his answers to a number of questions, Mr Seymour-Hamilton having described the hearing as an 'exploratory meeting' and indicating a lack of knowledge in a number of areas to do with veterinary practice and its regulation. The Committee felt that this demonstrated a fundamental lack of understanding as to its function and terms of reference.
Professor Noreen Burrows, chairing the Committee and speaking on its behalf, said: "The Committee expresses its surprise and concern at the lack of preparation for this hearing by the applicant, given that these issues have arisen at his previous restoration hearings, and that the result of a positive finding in favour of him would be his ability to practise unfettered as a veterinary surgeon forthwith."
In particular the Committee highlighted Mr Seymour-Hamilton's lack of understanding of the regulatory framework for veterinary practice as set out in the RCVS Code of Professional Conduct, the requirements of continuing professional development and what 'fitness to practise' meant, beyond the practical issues of his physical and mental capacity.
Professor Burrows added: "Based on all of the evidence available to the Committee it is very clear that he has failed to satisfy... that he is fit to be restored to the Register and this application is therefore dismissed."
The Committee's full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
The National Office of Animal Health Code of Practice Committee has found MSD Animal Health in breach of the NOAH Code on promotion for its advertisment for Equilis Prequenza.
The advert appeared in three separate issues of Veterinary Times (15, 22 and 29 September 2014), on the rear back cover of the 2014 BEVA Congress proceedings, and on the inside back cover of the 2014 Congress Planner. It contained the phrase “Neuraminidase antibodies provided a degree of protection in the case of HA strain/vaccine mismatch”, when viewed against the context of the advertisement headed ‘Why have part when you can have it all?”.
The Committee’s view was that the item in the context of the advertisement was intended to mean, and did convey, the meaning that the inclusion of NA antigens in an equine vaccine gave that vaccine a clinical advantage over vaccines which did not. This claim was not substantiated. Accordingly, the Committee found the phrase in breach of Code of Practice Clauses 4.1(iii) misleading, 4.1(vi) contained an exaggerated claim, 4.1(vii) implied it had a special merit which was not substantiated, 4.2(i) was not accurate and 4.2(ii) was not based upon an up-to-date evaluation of all the evidence.
Full details of the Committee’s rulings can be found on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
Axiom Laboratories has launched MiPetAllergy, a pet allergy test which the company says is not affected by medication and which requires no withdrawal period prior to testing.
Axiom developed the MiPetAllergy in partnership with ALK, which makes Artuvetrin. With its food elimination diet selector tool, developed in association with Royal Canin, it tests against as many as 80 environmental allergens and foods.
Dan Sherry, General Manager at Axiom, said: "Allergies are increasing among companion animals and identifying accurately which allergen is causing the problem in a particular pet can be one of the toughest challenges veterinary staff face in practice.
"MiPetAllergy represents two and half years of research so we are delighted to announce its arrival. Axiom is confident that there will be complete concordance between the screen and panel results that they are offering a money back guarantee if they are discordant. We hope it will help practices dealing with allergy patients to identify and treat for the specific allergens causing their symptoms."
Martyn Carpenter, Director of Axiom, added: "The introduction of the MiPetAllergy testing is timely as it coincides with the change in Axiom’s supplier of immunotherapy. During November and December 2014 the Veterinary Medicines Directorate (VMD) started rejecting applications for STC’s and advising that European Licensed immunotherapy products should now be used in the UK as part of the Cascade. Both our new allergy test and new vaccines are manufactured by the same company."
The RCVS has announced a total of £1 million funding to address mental health and wellbeing within the veterinary profession over the next five years.
The RCVS Operational Board has agreed £100K of funding for the first year of the Mind Matters initiative, with a view to a similar amount per year for the subsequent four years.
Additionally, the College says it intends to contribute approximately £500K over the next five years to the Veterinary Surgeons' Health Support Programme (VSHSP). This is a continuation of previous funding, effectively doubling the College's contribution. The VSHSP, independently run by the Veterinary Benevolent Fund, offers a confidential service that aims to combat problems with alcohol, drugs, eating disorders and other addictive and mental health issues. Neil Smith, Mind Matters' Chair said: "I am delighted that we have £500K of new funding over the next five years to dedicate to improving the mental health and wellbeing of the veterinary team, together with the increase to our support for the VSHSP. It shows the College's commitment in this vital area, and is a substantial amount that will really help change lives."
The funding will be reviewed annually as part of the RCVS budgeting process.
Mind Matters activities will fall into five streams:
Mind Matters is supported by a taskforce comprising the Veterinary Benevolent Fund, the British Veterinary Association, the British Veterinary Nursing Association, the Veterinary Practice Management Association, the Veterinary Schools Council, the Veterinary Defence Society, the Society of Practising Veterinary Surgeons and the Association of Veterinary Students.
Benchmark Holdings has announced that it has acquired Improve International limited, the Swindon-based veterinary Continuing Professional Development (CPD) business.
Improve will be added to Benchmark's Technical Publishing division, which provides global knowledge transfer, technical insight, e-learning and market analysis for people and businesses working in agriculture, aquaculture and the food supply chain.
Established in 1998 by a group of veterinary surgeons, Improve organises CPD courses for veterinary professionals across the UK, Republic of Ireland, Scandinavia and mainland Europe from its bases in the UK and Portugal.
Improve's courses are run privately and are accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and/ or Harper Adams University.
In partnership with ESVPS and Harper Adams University, Improve also provides courses and qualifications for Official Veterinarians in England, Scotland and Wales.
Improve's veterinary directors, David Babington (pictured right), Heber Alves and Rui Lobao will all remain with the business.
Benchmark's management says it believes there is considerable scope for online development of the courses within the digital arm of its Technical Publishing division. The division currently offers 15 distance-learning courses, which are tailored to develop core industry skills.
Malcolm Pye, Chief Executive of Benchmark Holdings Plc said: "The acquisition of Improve will enable us to combine our digital and distance learning expertise with Improve's veterinary content across Europe, enhancing our ability to serve the professionals in our key veterinary markets.
"This is a significant step forward for our Technical Publishing division in both of the food and companion animal markets. We plan to take Improve's successful, face-to-face courses and deliver content digitally on an international basis."
Virbac has launched Deltanil, a deltamethrin-based pour-on solution indicated in dairy and beef cattle for use against flies and lice with a zero milk withdrawal period. It is also effective in sheep against ticks, lice, keds and blowfly strike and against lice and ticks in lambs.
Deltanil is presented for use with the company's Farmpack and Flexibag dispensing system, which was awarded the 2014 PharmaPack Award for Innovative Packaging. Virbac says the system offers farmers a convenient approach to treatment, combining easy application with freedom of movement and the flexibility of a long stability period once the product is opened.
The Farmpack backpack holds a 2.5 litre Flexibag of Deltanil solution, sufficient for the treatment of 250 cattle.
The Flexibag is a flexible, multi-layered, multi-component bag designed to protect and preserve medication, giving Deltanil a two year proven stability period after opening. Unopened, Deltanil has a three year shelf life.
Virbac Product Manager for Large Animals Brigitte Goasduf MRCVS said: "External parasites are a year-round threat to dairy and beef herds and can have a significant economic impact on yields. With the launch of Deltanil, we are offering a new approach to product application, one which is ideally suited to the practical conditions on farm and which addresses the challenges often faced in using pour ons.
"We believe that Deltanil, with its zero milk withdrawal period for dairy cattle and sheep and innovative Farmpack and Flexibag dispensing system, sets a new standard for products of this type.
"Deltanil is based on deltamethrin, a tried and trusted parasiticide. It offers a convenient approach to administration with a 10ml dosage per cow, irrespective of weight, and is presented in two sizes - the 2.5 litre Flexibag and a 1litre dispensing bottle. The 1litre bottle offers a year's stability once opened. The dosage per sheep is 5ml, irrespective of weight, with a 2.5ml dosage for lambs."
Virbac has launched the BackHome Mini Chip, a microchip which is 8mm long compared to the existing standard which is 12mm.
The new Mini Chips are made of a pharmaceutical grade glass with an anti-migration coating. Because of their smaller size, they can be implanted with a needle that is 34% smaller than the standard needle. Virbac says this can minimise stress and discomfort during implantation.
Virbac has also announced a partnership with VetEnvoy, a service which works with practice management software to enable pet and owner registration details for BackHome Mini Chips to be uploaded to the Petlog database at the press of a button, saving support staff time completing online or paper application forms and reducing the number of errors.
Sarah Walker MRCVS, Product Manager, said: "Microchipping is the most effective way for owners to protect their pets and will soon become compulsory for dogs in England and Wales. Some owners are deterred from undertaking this important and simple procedure because they are concerned that it may be painful. Because our new BackHome Mini Chips are smaller and are implanted with a smaller needle, we hope that practices will be able to reassure their clients that microchipping will not cause their pet discomfort - and that the protection it offers will last a lifetime.
“Our relationship with VetEnvoy will also spare enabled practices some of the administration time spent processing microchip details, and reduce the number of mistakes in registration and any resulting complaints.
"Client information on BackHome Mini Chips is stored on Petlog, the UK's largest pet database, giving owners the best possible chance of being reunited with their pet, as long as they keep their registration details up to date."
The RCVS has announced that this year, for the first time, it will accept debit card payments from veterinary surgeons who are renewing their registration.
The annual renewal fee should be paid by 31 March. Those who have not paid by 30 April will be charged an extra £35 to renew their registration while those who have not paid by 31 May will be removed from the Register.
Corrie McCann, RCVS Director of Operations, said: "Following feedback from the profession, this year, thanks to a change in our registration regulations, we are able to accept debit card payments which we hope will make the renewal process much easier and more convenient for our members. Furthermore, members will also no longer be charged if they choose to pay their fee by credit card."
Veterinary surgeons will also need to confirm their registration details (including their correspondence and registration addresses), confirm that they have met the RCVS requirement for continuing professional development of 105 hours over a three-year period and disclose any new or previously undisclosed convictions, cautions or adverse findings.
Another change is that vets will now have the choice of either home or work as their registered address (in the past, only work addresses were allowed).
The annual renewal can be completed by returning the form that has been sent by post or by logging into the 'My Account' area of the RCVS website (www.rcvs.org.uk/login) using the security details that have been sent to all MsRCVS.
Any members who have not received their annual renewal form or security details for the 'My Account' area should contact the RCVS Registration Department on 020 7202 0707 or registration@rcvs.org.uk as soon as possible.
Those with queries about paying the annual renewal fee should contact the RCVS Finance Team on 020 7202 0733 or finance@rcvs.org.uk
The British Equine Veterinary Association (BEVA) is urging veterinary surgeons to be on the lookout for outbreaks of Atypical Myopathy (AM) this spring.
Atypical Myopathy is a serious muscle disease found in the UK and Northern Europe. It is linked to horses eating the seeds from trees in the Acer family, including sycamore and box elder. There were more than five times as many cases of AM last autumn than in the previous year and experts have warned that the disease tends to occur more frequently in the spring following an autumn surge, possibly because of the growth of seedlings. The prognosis is poor, with survival rates of less than 25%. Early diagnosis is essential to give the best chance of survival.
Horses that develop AM are usually kept on sparse pastures, near trees from Acer pleudoplatanus (sycamore) or Acer negundo (box elder, pictured right) that shed seeds containing the toxin hypoglycin A. They are often not fed any supplementary hay or feed and may be driven to browse on an accumulation of dead leaves, dead wood and trees in or around the pasture but sometimes well-fed animals are affected. While the tree seeds may not be directly palatable, horses on poor quality grazing may ingest considerable numbers of them.
The clinical signs of AM may include muscle weakness or stiffness, colic-like symptoms, laboured breathing, dark red-brown urine, recumbency or even sudden death. Often the disease will present as an outbreak. Confirmation of diagnosis is by a blood or urine test. The toxin directly targets aerobic energy metabolism so therapy should be targeted at promoting glucose metabolism and provided fluid dieresis.
Preventative advice for horse owners includes:
Professor Celia Marr, Partner at Rossdales, Newmarket, European Specialist in Equine Internal Medicine and Editor of Equine Veterinary Journal said: "New, collaborative research, instigated last year between the University of Liege, the Irish Equine Centre and the Animal Health Trust should shed more light on the characteristics of the disease in this country. Once we know more about the specific causes we should be able to make more positive progress with prevention strategies."
BEVA has provided free online access to two articles from the journal of Equine Veterinary Education on the disease for all vets to help them address the threat.
Volume 25, Issue 5, pages 264-270, May 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 1: First aid, cardiovascular, nutritional and digestive care (pages 264-270) G. van Galen and D -M Votion.
Volume 25, Issue 6, pages 308-314, June 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 2: Muscular, urinary, respiratory and hepatic care, and inflammatory/infectious status (pages 308-314) G van Galen and D - M Votion.
Kruuse has launched the Buster Premium Dog Collar, described as the greatest innovation in Elizabethan dog collars since the original.
The company says the new collar has been designed with two things in mind. First and foremost, patient comfort. Secondly, ease-of-use. Both should help improve compliance.
The new product uses perforated neoprene to provide a snug fit round the neck with no need to attach a separate collar. It's fastened using Velcro, to give a quick but secure fitting. There's padded banding around the inner edge to provides extra comfort and prevent skin irritation, and additional banding around the outer edge to protect the dog's surroundings.
Andrew Groom, Managing Director at Kruuse said: "Worldwide, the Buster collar is the most trusted device to prevent canine patients from biting or licking their body or scratching their head and neck while wounds or injuries heal. The functionality of an e-collar is outstanding when it comes to postoperative care and prevention of self-inflicted trauma.
"The new Buster Premium Collar has been developed in association with vets, vet nurses and dog owners to provide an exceptional collar that is as stress-free as possible for the patient whilst providing exceptional functionality for the user both at the veterinary hospital and at home."
The Premium Buster Collar is available exclusively via NVS: www.vetwholesaler.co.uk
Bayer has announced that it has launched a new bone-shaped version of the Drontal Plus tablet with greatly increased palatability to increase client compliance.
In a field study, new Drontal Dog Tasty Bone proved to be voluntarily consumed by 88% of 150 dogs1.
Vicky McAlister, Group Product Manager at Bayer said: "We want to make it as easy as possible for responsible dog owners to remember to worm their pet at least every three months. To help improve compliance, there is an increased necessity for highly palatable oral dosage forms. To meet this need, the Drontal Plus Tasty tablet has been optimised using a novel formula that has an extremely high level of palatability where the majority of dogs take the tablet straight out of the owners hand like a treat - proving that Drontal is now tasty by nature as well as name!
This combined with the memorable bone-shaped design will help cement Drontal as the wormer of choice in the minds of owners."
Is it just me, or does the name of this product sound a bit like someone who has ingested a series of words, and then regurgitated them in no particular order? I suppose Drontal Tasty Dog Bone means something else, and Tasty Dog Drontal Bone doesn't really work.
Reference
Freda Andrews, the Director of Education at the RCVS, has announced her retirement from the position on 2nd April after nearly 16 years at the College.
Freda joined the RCVS as Head of Education in September 1999 and became Director of Education in 2013, with strategic responsibility for both veterinary and veterinary nursing education.
Nick Stace, RCVS Chief Executive Officer, said: "We will miss Freda for her professionalism, her encyclopaedic knowledge of all things related to veterinary education and her attention to detail, but she leaves behind a team that is stronger-than-ever and a considerable legacy for the profession as a whole.
"Under her watch the Education Department has seen a significant number of achievements. This includes the introduction of the Professional Development Phase which has helped veterinary graduates develop their confidence and competence during the first few years of practice and the accreditation of the University of Nottingham's School of Veterinary Medicine and Science - the first new UK vet school in 50 years."
Freda's responsibilities as Director of Education will now be split between Christine Warman, Head of Education, and Julie Dugmore, Head of Veterinary Nursing.
Freda said: "I have really enjoyed working with such a fascinating profession and I think that through working very closely with our colleagues in the vet schools, as well as with practising vets, veterinary education has made some significant advances. For example, there is more focus now on communication and professional skills and greater alignment of accreditation standards internationally, to name but two things.
"I am sad to leave but I know that the future of veterinary and veterinary nursing education has been left in the very safe hands of Christine and Julie and their respective teams."
MSD Animal Health has announced the launch of The Big Tick Project, both to investigate whether ticks are carrying more pathogens and to raise awareness amongst the public.
The company highlights research which shows that nationally, tick distribution has expanded by 17% in the last 10 years and tick numbers have also increased in 73% of locations surveyed.1 In addition, the company says there is evidence that ticks are feeding earlier in the year and feeding for longer2, thus increasing their potential to pass on significant disease to both animals and humans. Lyme disease in particular can be serious health issue for both humans and animals, being increasingly recognised and recorded in the UK recent years3.
So, as part of the project, practices are being invited to collect ticks and send them to the University of Bristol for analysis. In addition, there'll be a national PR and marketing campaign fronted by the naturalist Chris Packham (pictured right).
Practices taking part in the project will receive a tick collection kit and marketing support pack including access to dedicated PR services, postcards and posters to raise awareness of ticks within their clinic and local community. The collection kit includes instructions, collection equipment and Freepost packaging to allow ticks removed from dogs to be sent to the university quickly and easily.
Professor Richard Wall from University of Bristol said: "For accurate results we need as many ticks as possible and I really encourage vet practices up and down the country to get involved. We need data from all types of practices ranging from urban to rural locations to help vets and human health professionals make more effective recommendations and help prevent tick-related disease."
To take part in The Big Tick Project, email a contact name and your practice details to: info@bigtickproject.co.uk.
References
New research1 published in in the Journal of Feline Medicine and Surgery by veterinary clinicians at the University of Lisbon and a clinic in the nearby town of Barreiro in Portugal, suggests that cats may benefit from reduced anxiety, stress and perceived pain if music is played in the operating theatre.
Lead author, Miguel Carreira, said: "In the surgical theatres at the faculty where I teach and at the private veterinary medical centre where I spend my time operating, environmental music is always present, and is an important element in promoting a sense of wellbeing in the team, the animals, and their owners. Different music genres affect individuals in different ways. During consultations I have noticed, for example, that most cats like classical music, particularly George Handel compositions, and become more calm, confident and tolerant throughout the clinical evaluation. After reading about the influence of music on physiological parameters in humans, I decided to design a study protocol to investigate whether music could have any physiological effects on my surgical patients."
The clinicians studied 12 female pet cats undergoing surgery for neutering, and recorded their respiratory rate and pupil diameter at various points to gauge their depth of anaesthesia. The cats, which had been fitted with headphones, were meanwhile exposed to 2 minutes of silence (as a control), followed randomly by 2 minutes each of Barber’s 'Adagio for Strings (Opus 11)', Natalie Imbruglia’s 'Thorn' and AC/DC’s 'Thunderstruck'.
The results showed that the cats were in a more relaxed state (as determined by their lower values for respiratory rate and pupil diameter) under the influence of classical music, with the pop music producing intermediate values. By contrast, the heavy metal music produced the highest values, indicating 'a more stressful situation'. The clinicians conclude that the use of certain music genres in the surgical theatre may allow a decrease in the dose of anaesthetic agent required, in turn reducing the risk of undesirable side effects and thus promoting patient safety.
Dr Carreira and his colleagues plan to continue their studies by looking at the influence of music on other physiological parameters, including cortisol and catecholamines, in dogs as well as cats. In the future, they hope to incorporate more sophisticated techniques, such as functional MRI and electroencephalography, into their investigations.
The study can be read for free here: http://jfm.sagepub.com/content/early/2015/03/30/1098612X15575778.full.pdf+html
Merial is to launch Frontect (fipronil and permethrin), a spot-on solution for dogs with dual action: treatment and prevention of fleas and ticks, and repellency against ticks, sandflies, biting flies and mosquitoes.
According to the company, Frontect kills fleas within an hour for the first week and within six hours for four weeks1. The repellent (anti-feeding) effect of Frontect prevents parasites from taking a 'blood meal' and as a result, Merial says vets and pet owners can feel confident that they are helping to protect dogs from the vectors of severe canine diseases - including leishmaniosis, dirofilariosis, babesiosis, anaplasmosis, ehrlichiosis and borreliosis - whether travelling within the UK or abroad.
Lynda Maris, Brand Manager for Frontect said: “We are delighted to expand our Merial V-Line vet exclusive parasiticide portfolio with the addition of Frontect. Frontect both kills and repels parasites to provide visible results and help deliver client satisfaction. Frontect is ideal for active, outdoor dogs and travelling dogs at risk of exposure to ticks and vector borne diseases.”
Frontect is administered topically, on the neck and between the shoulder blades of the dog. It will be available in five different weight ranges to suit all dogs from the beginning of May 2015.
CPC has announced the opening of a new pet crematorium in Tewkesbury, Gloucestershire to meet rising demand.
According to the company, there has been an increase of 12% in individual pet cremations over the last four years, and about half the pets that come to the company from Vets Now are given individual cremations, rather than communal ones. Of the pet owners that contact CPC directly, about a third currently ask for an individual cremation, up from a quarter in 2008.
Jason Cracknell, the General Manager at CPC (pictured right), said: "When I was a child growing up in the country, our pets were buried in the garden. With smaller gardens and greater mobility this is no longer an option for many. Working closely with vets we have seen a considerable increase in owners wanting more knowledge and involvement in how their beloved pet is cared for at the end of its life."
The new Cheltenham Pet Crematorium will have a memorial and wildlife garden designed with the help of year 9 students from the nearby Tewkesbury School. It'll be officially opened at the end of April by farmer and television presenter, Adam Henson.
CPC also offers three levels of pet bereavement training for veterinary practices that use its services:
For more information, visit www.cpccares.com
A new company supplying pet chews to the veterinary profession has launched this month.
The Soft Chew Company has been set up by Kevin Ingram, owner of the veterinary supplier J.A.K Marketing and Niall McFerran, who has in the past worked for a number of veterinary healthcare companies including Animalcare, Ceva and Alstoe.
Kevin said: "The healthcare supplement market in the UK is worth over £20 million and rising but most customers are asked to use products which were designed for use on humans. The aim of The Soft Chew Company is to provide those health benefits in the form of treats that the dogs and cats will readily accept."
The new company's product range will be branded: "Chewz" and marketed as palatable healthcare supplements in order that they will not be confused with pharmaceutical products.
The range will initially consist of:
The Chewz range can be obtained from all wholesalers or directly from J.A.K Marketing.
For further information contact; info@thesoftchewcompany.co.uk or 01347 293150
Labrador Retrievers are the breed most likely to run away, according to a survey of 2000 pet owners commissioned by the Blue Cross.
In addition, the survey found that the average dog owner has had their pet run off three times. One in five haven't had their dog microchipped and half of those say they probably won't ever have it done.
Only 23% of dog owners know it is already mandatory for dogs to wear a tag when in public, and only half of those knew the tag must bear the owner's name.
1/3rd thought the maximum fine for a dog being without a tag would be £100, when it is actually £5000.
The full list of breeds most likely to do a runner was:
The Society of Practising Veterinary Surgeons (SPVS) has launched its 2015 Fee Survey, which enables veterinary practices to review their pricing structure and benchmark it against other practices around the country.
Open to both SPVS members and non-members, SPVS is encouraging all practices to complete a questionnaire to give as accurate a picture as possible of the fees charged by veterinary practices nationwide.
SPVS says the questionnaire does not take long to complete and covers everything from vaccinating, microchipping and neutering small animals to calving and routine on-farm fertility work in livestock practices and performing a five stage vetting and dental work in equine practices.
Peter Brown, author of the survey and SPVS Council member said: "The Fee Survey has become the go to resource for benchmarking pricing in the veterinary profession. The variation in individual fees can be marked and the survey allows practices to see that their fees are calculated in a realistic way to reflect their individual costs and overheads as well as local market conditions."
To take part in the survey, visit: http://www.spvs.org.uk/content/fees-survey-questionnaire-2015 or for a printed questionnaire, ring 01926 410454.
Boehringer Ingelheim has announced that Vetmedin Chewable Tablets have been licensed for treating pre-clinical dilated cardiomyopathy (DCM) in Doberman Pinschers1.
Boehringer says DCM is the most common form of cardiomyopathy in dogs and the second most common form of acquired heart disease in dogs. Typically, up to half (25 - 50%) of Doberman Pinschers develop DCM in their lifetime and before congestive heart failure (CHF) develops, over a quarter (25 - 30%) of these dogs will suffer sudden death. Despite optimal treatment, survival time once in CHF is short at just 2 - 4 months, with a fatality rate of at least 90% after a year.
The new indication was granted following a study which showed that early intervention with Vetmedin at pre-clinical stages in Dobermans can significantly delay the onset of CHF, increasing life expectancy and quality of life for patients2.
Robert Lucy, Vetmedin brand manager, Boehringer Ingelheim UK, said: "The PROTECT study, and the resulting new indication for Vetmedin is groundbreaking. For the first time ever, we are now not only able to manage congestive heart failure, but to significantly delay it. By acting sooner, we'll be able to alter the course of disease progression, ultimately increasing survival and allowing more pet owners to spend more time with their beloved dogs. Key to this will be giving vets the support and confidence in recognising the subtle signs of pre-clinical DCM. We plan to support veterinary professionals with new educational materials, including a screening algorithm, to help the diagnostic process."
Traditionally, there have been no licensed therapies available to vets to slow the progression of heart disease during the pre-clinical stage. However, peer-reviewed independent data from PROTECT, the first study in veterinary cardiology of its kind, proves that early intervention with Vetmedin at pre-clinical stages in Dobermans Pinschers can significantly delay the onset of CHF, increasing life expectancy and quality of life for patients.